RxDoctor Payments Data

Tan Tran, PA

Physician Assistant · Dallas, TXNPI 1528116894

Payments from drug & device makers

$768in general payments, 2019–2025

Across 31 payments — averaging $24.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$142
  • Janssen Scientific Affairs, LLC$86
  • Karyopharm Therapeutics Inc.$83
  • Seagen Inc.$80
  • Bristol Myers Squibb$74
  • Pfizer$64
  • plus $238 from 9 others

What the payments were for

  • Food & beverage$65485%
  • Education$11415%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$768 in reported general payments places this provider in the 60th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$37,309
Medicare patients
227
Services billed
480

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TagrissoOsimertinib Mesylate15$237,408
XtandiEnzalutamide15$209,375
CalquenceAcalabrutinib Maleate12$163,099
InlytaAxitinib13$151,422
EliquisApixaban52$33,362
Abiraterone Acetate34$27,933
Anastrozole28$555
Potassium Chloride17$487
Letrozole21$405
Pantoprazole Sodium17$362
Gabapentin26$272
Ondansetron Hcl22$245
Levothyroxine Sodium21$238
Acyclovir16$170
Prednisone19$77

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaTagrisso, Calquence$17$400,50727 claims
PfizerInlyta, Eliquis$64$184,78365 claims
Janssen Scientific Affairs, LLCAbiraterone Acetate$86$27,93334 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →